These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22339813)

  • 1. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis.
    Skjøt-Arkil H; Schett G; Zhang C; Larsen DV; Wang Y; Zheng Q; Larsen MR; Nawrocki A; Bay-Jensen AC; Henriksen K; Christiansen C; Alexandersen P; Leeming DJ; Karsdal MA
    Clin Exp Rheumatol; 2012; 30(3):371-9. PubMed ID: 22339813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
    J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitis.
    Veidal SS; Larsen DV; Chen X; Sun S; Zheng Q; Bay-Jensen AC; Leeming DJ; Nawrocki A; Larsen MR; Schett G; Karsdal MA
    Clin Biochem; 2012 May; 45(7-8):541-6. PubMed ID: 22382088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover.
    Siebuhr AS; Petersen KK; Arendt-Nielsen L; Egsgaard LL; Eskehave T; Christiansen C; Simonsen O; Hoeck HC; Karsdal MA; Bay-Jensen AC
    Osteoarthritis Cartilage; 2014 Jan; 22(1):44-50. PubMed ID: 24216059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients.
    Zayani Y; El Golli N; Zidi W; Guizani I; Boussairi S; Aloui S; Ayadi I; Ftouhi B; Feki M; Ben Romdhane N; Ben Sliman H; Allal-Elasmi M; Kaabachi N
    Cytokine; 2016 Oct; 86():47-52. PubMed ID: 27455450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Cathepsin S and hs-CRP predicting inflammation of abdominal aortic aneurysm.
    Qin Y; Yang Y; Liu R; Cao X; Liu O; Liu J; Wang M; Yang Y; Chen Z; Zhang H; Du J
    Clin Biochem; 2013 Aug; 46(12):1026-1029. PubMed ID: 23742758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation.
    Skjøt-Arkil H; Clausen RE; Nguyen QH; Wang Y; Zheng Q; Martinez FJ; Hogaboam CM; Han M; Klickstein LB; Larsen MR; Nawrocki A; Leeming DJ; Karsdal MA
    BMC Pulm Med; 2012 Jul; 12():34. PubMed ID: 22818364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.
    Mattey DL; Packham JC; Nixon NB; Coates L; Creamer P; Hailwood S; Taylor GJ; Bhalla AK
    Arthritis Res Ther; 2012 May; 14(3):R127. PubMed ID: 22640827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression.
    Bay-Jensen AC; Karsdal MA; Vassiliadis E; Wichuk S; Marcher-Mikkelsen K; Lories R; Christiansen C; Maksymowych WP
    Arthritis Rheum; 2013 Apr; 65(4):972-80. PubMed ID: 23280360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis.
    Claushuis TA; de Vries MK; van der Weijden MA; Visman IM; Nurmohamed MT; Twisk JW; Van der Horst-Bruinsma IE; Crusius JB
    Clin Exp Rheumatol; 2015; 33(2):159-65. PubMed ID: 25603416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study.
    Bay-Jensen AC; Leeming DJ; Kleyer A; Veidal SS; Schett G; Karsdal MA
    Rheumatol Int; 2012 Nov; 32(11):3565-72. PubMed ID: 22086471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis.
    Siebuhr AS; Bay-Jensen AC; Karsdal MA; Lories RJ; de Vlam K
    Biomark Med; 2016; 10(2):197-208. PubMed ID: 26764293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort.
    Saberi Hosnijeh F; Siebuhr AS; Uitterlinden AG; Oei EH; Hofman A; Karsdal MA; Bierma-Zeinstra SM; Bay-Jensen AC; van Meurs JB
    Arthritis Res Ther; 2016 Apr; 18():81. PubMed ID: 27039382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
    Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
    Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
    Maksymowych WP; Landewé R; Conner-Spady B; Dougados M; Mielants H; van der Tempel H; Poole AR; Wang N; van der Heijde D
    Arthritis Rheum; 2007 Jun; 56(6):1846-53. PubMed ID: 17530713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease.
    Rasmussen DG; Sand JM; Karsdal MA; Genovese F
    PLoS One; 2017; 12(1):e0170023. PubMed ID: 28076408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.
    Kim TH; Stone M; Payne U; Zhang X; Ionescu M; Lobanok T; King L; Poole AR; Inman RD
    Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.